Targeting ferroptosis protects against experimental (multi)organ dysfunction and deathSamya Van Coillie, Tom Vanden Berghe, Eric A. J. Hoste et al.|Nature Communications|2022Cited by 176
Fatal Lymphocytic Cardiac Damage in Coronavirus Disease 2019 (COVID-19): Autopsy Reveals a Ferroptosis SignatureWerner Jacobs, Philippe G. Jorens, Martin Lammens et al.|ESC Heart Failure|2020Cited by 142
Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progressionEmily Van San, Tom Vanden Berghe, Angela C. Debruyne et al.|Cell Death and Differentiation|2023Cited by 93
Ferroptosis is a targetable detrimental factor in metabolic dysfunction-associated steatotic liver diseaseCédric Peleman, Tom Vanden Berghe, Stig Hellemans et al.|Cell Death and Differentiation|2024Cited by 36
Viral dosing of influenza A infection reveals involvement of RIPK3 and FADD, but not MLKLTeodora Oltean, Peter Vandenabeele, Emily Van San et al.|Cell Death and Disease|2021Cited by 27